Aureus Asset Management’s United Therapeutics UTHR Stock Holding History

Aureus Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Hold	2,500	–	–	0.08%	106
2026 Q1	$1.48M	Hold	2,500	–	–	0.1%	92
2025 Q4	$1.22M	Buy	+2,500	New	+$1.16M	0.08%	89
2024 Q1	–	Sell	-2,500	Closed	-$550K	–	207
2023 Q4	$550K	Hold	2,500	–	–	0.04%	109
2023 Q3	$565K	Hold	2,500	–	–	0.05%	111
2023 Q2	$552K	Hold	2,500	–	–	0.04%	111
2023 Q1	$560K	Hold	2,500	–	–	0.04%	112
2022 Q4	$695K	Hold	2,500	–	–	0.06%	107
2022 Q3	$523K	Hold	2,500	–	–	0.05%	117
2022 Q2	$589K	Hold	2,500	–	–	0.05%	117
2022 Q1	$449K	Buy	+2,500	New	+$476K	0.03%	152

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Aureus Asset Management's UTHR Position: Q2 2026 in Review

Aureus Asset Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 2,500 shares worth $1.35M. The position accounts for 0.08% of the portfolio, ranked #106.

Aureus Asset Management first reported a position in UTHR in Q1 2022 and has held it in 11 quarters since. The position peaked at $1.48M in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Aureus Asset Management held 2,500 shares of United Therapeutics worth $1.35M as of Q2 2026.
Aureus Asset Management left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up 0.08% of Aureus Asset Management's portfolio in Q2 2026, its #106 holding.
Aureus Asset Management first reported a position in United Therapeutics in Q1 2022 and has held it in 11 quarters since.
Aureus Asset Management's United Therapeutics position peaked at $1.48M in Q1 2026.
878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Aureus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.